Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Non-Muscle Invasive Bladder Neoplasms × Polysorbates × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Non-Muscle Invasive Bladder Neoplasms 1 Carcinoma, Transitional Cell 1 Breast Neoplasms 1

Interventions

apaziquone 4 Mitomycin 2 valrubicin 1 linrodostat 1 enfortumab vedotin 1 avelumab 1 Sugars 1 Standard of Care 1 Polysorbates 1 Pentosan Sulfuric Polyester 1 Nivolumab 1 Gemcitabine 1 DDMS 1 Capsules 1 Bevacizumab 1 ALT-801 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02982395 2019-08-30

Study to Evaluate the Efficacy and Safety Of Intravesical Nanoxel®M In BCG Refractory NMIBC

Samyang Biopharmaceuticals Corporation

Phase 3 Terminated

Non-Muscle Invasive Bladder Neoplasms, Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡